Levemir FlexPen 100iu/ml 3ml 1`s

KSh2,000.00

Categories Anti-Diabetics, PHARMACY ONLY

Share On

Product Description

Levemir FlexPen is indicated to improve glycemic control in adult and pediatric patients with diabetes mellitus.

Levemir^??is contraindicated during episodes of hypoglycemia and in patients hypersensitive to Levemir^??or any of its excipients. Reactions have included anaphylaxis.
Never Share a Levemir^??FlexTouch^? Pen, Needle, or Syringe Between Patients
Hyperglycemia or Hypoglycemia with Changes in Insulin Regimen: Changes in an insulin regimen may affect glycemic control and predispose to hypoglycemia or hyperglycemia.
Hypoglycemia:?Hypoglycemia is the most common adverse reaction of insulin, including Levemir^?, and may be life-threatening.
Hypersensitivity and Allergic Reactions:?If hypersensitivity reactions occur, discontinue Levemir^?; treat per standard of care and monitor until symptoms and signs resolve. Levemir^??is contraindicated in patients who have had hypersensitivity reactions to insulin detemir or any of the excipients.
Hypokalemia:?All insulin products, including Levemir^?, cause a shift in potassium from the extracellular to intracellular space, possibly leading to hypokalemia.
Fluid Retention and Heart Failure with Concomitant Use of PPAR-gamma Agonists: Thiazolidinediones (TZDs), which are peroxisome proliferator-activated receptor (PPAR)-gamma agonists, can cause dose-related fluid retention, particularly when used in combination with insulin